Feng Liu

Feng Liu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
FGFeng-Hou Gao
Feng-Hou Gao
XHXiao-Hui Hu
Xiao-Hui Hu
WLWei Li
Wei Li
HLHua Liu
Hua Liu
YZYan-Jie Zhang
Yan-Jie Zhang
YWYingli Wu
Yingli Wu
Background: Oridonin, a tetracycline diterpenoid compound, has the potential antitumor activities. Here, we evaluate the antitumor activity and action mechanisms of oridonin in colorectal cancer. Methods: Effects of oridonin on cell proliferation were determined by using a CCK-8 Kit. Cell cycle distribution was determined by flow cytometry. Apoptosis was examined by analyzing subdiploid population and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay. Senescent cells were determined by senescence-associated β-galactosidase activity analysis. Semi-quantitative RT-PCR was used to examine the changes of mRNA of p16, p21, p27 and c-myc. The concomitant changes of protein expression were analyzed with Western blot. Expression of AcH3 and AcH4 were examined by immunofluorescence staining and Western blots. Effects of oridonin on colony formation of SW1116 were examined by Soft Agar assay. The in vivo efficacy of oridonin was detected using a xenograft colorectal cancer model in nude mice. Results: Oridonin induced potent growth inhibition, cell cycle arrest, apoptosis, senescence and colony-forming inhibition in three colorectal cancer cell lines in a dose-dependent manner in vitro. Daily i.p. injection of oridonin (6.25, 12.5 or 25 mg/kg) for 28 days significantly inhibited the growth of SW1116 s.c. xenografts in BABL/C nude mice. With western blot and reverse transcription-PCR, we further showed that the antitumor activities of oridonin correlated with induction of histone (H3 and H4) hyperacetylation, activation of p21, p27 and p16, and suppression of c-myc expression. Conclusion: Oridonin possesses potent in vitro and in vivo anti-colorectal cancer activities that correlated with induction of histone hyperacetylation and regulation of pathways critical for maintaining growth inhibition and cell cycle arrest. Therefore, oridonin may represent a novel therapeutic option in colorectal cancer treatment.

1 October 2017 in Oral Oncology
Verified
Journal Article
Closed access
YCYiMing Chen
YiMing Chen
SGSandhya Gokavarapu
Sandhya Gokavarapu
QSQingCheng Shen
QingCheng Shen
FLFeng Liu
Feng Liu
WCWei Cao
Wei Cao
TJTong Ji
Tong Ji

14 November 2017 in Cell Cycle
Verified
Journal Article
Closed access
SLShan-Ling Liu
Shan-Ling Liu
ZLZhen Liu
Zhen Liu
LZLi-Di Zhang
Li-Di Zhang
HZHan-Qing Zhu
Han-Qing Zhu
JGJia-Hui Guo
Jia-Hui Guo
FGFeng-Hou Gao
Feng-Hou Gao
Cyclin D1 and cyclin E1, as vital regulatory factors of G1-S phase cell cycle progression, are frequently constitutive expressed and associated with pathogenesis and tumorigenesis in most human cancers and they have been regarded as promising targets for cancer therapy. In this study, we established NVP-BEZ235, a potent dual kinase inhibitor, could induce neuroblastoma cells proliferation inhibition without apoptosis activation. Moreover, we showed NVP-BEZ235 could induce neuroblastoma cells arrested at G0/G1 phase accompanied with significant reduction of the cyclin D1 and E1 proteins in a dose dependent manner at nanomole concentration. Additionally we found that GSK3β was dephosphorylated and activated by NVP-BEZ235 and then triggered cyclin D1 and cyclin E1 degradation through ubiquitination proteasome pathway, based on the evidences that NVP-BEZ235 induced downregulation of cyclin D1 and cyclin E1 were obviously recovered by proteasome inhibitor and the blockade of GSK3β contributed to remarkable rescue of cyclin D1 and cyclin E1. Analogous results about its anti-proliferation effects and molecular mechanism were observed on neuroblastoma xenograft mouse model in vivo. Therefore, these results indicate that NVP-BEZ235-induced cyclin D1 and cyclin E1 degradation, which happened through activating GSK3β, and GSK3β-dependent down-regulation of cyclin D1 and cyclin E1 should be available for anticancer therapeutics.

1 November 2024 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Open access
LZLili Zhang
Lili Zhang
NDNan Dang
Nan Dang
JWJiongyi Wang
Jiongyi Wang
WZWenying Zhang
Wenying Zhang
XHXiaohua Hu
Xiaohua Hu
HYHaihua Yuan
Haihua Yuan
Microvascular invasion is strongly associated with aggressive tumor behavior and recurrence in hepatocellular carcinoma (HCC) patients. Zinc finger protein 143(ZNF143) is a transcription factor involved in a wide variety of physiological and developmental processes. This study primarily focuses on the exact biological role and mechanism of ZNF143 in HCC migration and invasion. The expression and prognosis of ZNF143 in HCC patients were analyzed. The levels of ZNF143, mex-3 RNA binding family member C (MEX3C) were quantified by western blot and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cell migration ability was detected by wound- healing assay. Matrigel transwell assay was conducted to evaluate the invasion of HCC cells. The differential expression genes of ZNF143 overexpression and knockdown were screened by mRNA profiling analysis. Dual luciferase assay was performed to determine the promoter activity of MEX3C. The enrichment of ZNF143 at MEX3C promoter was determined by chromatin immunoprecipitation (ChIP). ZNF143 is overexpressed in HCC tissues and that its overexpression is correlated with poorer prognosis, especially in HCC patients with higher tumor grades and microvascular invasion. Gain- and loss-of function experiments showed that ZNF143 promotes migration and invasion in HCC cells. mRNA profiling showed that ZNF143 significantly upregulates MEX3C. ZNF143 was positively correlated with MEX3C expression in HCC tissue. ZNF143 activates MEX3C transcription by directly binding to its promoter. MEX3C knockdown inhibited migration and invasion induced by ZNF143 overexpression in HCC cells. ZNF143 promotes HCC cell migration and invasion by binding to MEX3C promoter and activating its expression.

24 July 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
HZHan‐Qing Zhu
Han‐Qing Zhu
CZChao Zhang
Chao Zhang
ZGZhu‐Ying Guo
Zhu‐Ying Guo
JYJun‐Mei Yang
Jun‐Mei Yang
JGJia‐Hui Guo
Jia‐Hui Guo
FGFeng-Hou Gao
Feng-Hou Gao
Oridonin could induce NB (neuroblastoma) cells growth inhibition by inducing apoptosis and cell cycle arrest, and the molecular mechanisms behind the effects deserve to be further explored. Here, oridonin was confirmed to cause the reactivation of p53 (cellular tumor antigen p53) to promote the expression of a series of apoptosis‐ and cell cycle arrest‐related proteins for the biological effects. During the process, oridonin relied on the caspase activation to cleave p53‐induced Mdm2 (E3 ubiquitin‐protein ligase Mdm2) to generate Mdm2‐p60. The generation of Mdm2‐p60 stabilized p53, and resulted in p53 accumulation for p53 continuous activation. In our research, it was also found that the reactivation of p53 induced by oridonin was closely related with the generation of ROS (reactive oxygen species). Taken together, these findings explain that oridonin exerts its anticancer activity partially by targeting the Mdm2‐p53 axis in NB cells, which lay an experimental base for future research of exploring the effects and molecular mechanisms of oridonin.

6 July 2020 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
JGJia‐Hui Guo
Jia‐Hui Guo
HFHai‐Yun Fang
Hai‐Yun Fang
JYJun‐Mei Yang
Jun‐Mei Yang
SLShan‐Ling Liu
Shan‐Ling Liu
QYQiang‐Hua Yao
Qiang‐Hua Yao
FGFeng-Hou Gao
Feng-Hou Gao